169 related articles for article (PubMed ID: 26791973)
1. Endothelin Receptor A Antagonism and Fetal Growth in Endothelial Nitric Oxide Synthase Gene Knockout Maternal and Fetal Mice.
Luo K; Thaete LG; Neerhof MG
Reprod Sci; 2016 Aug; 23(8):1028-36. PubMed ID: 26791973
[TBL] [Abstract][Full Text] [Related]
2. Endothelin Receptor A Antagonism Prevents Damage to Glycogen-Rich Placental Cells Following Uterine Ischemia-Reperfusion in the Rat.
Thaete LG; Khan S; Neerhof MG
Reprod Sci; 2016 Nov; 23(11):1518-1525. PubMed ID: 27130231
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats.
Thaete LG; Neerhof MG; Silver RK
J Soc Gynecol Investig; 2001; 8(1):18-23. PubMed ID: 11223352
[TBL] [Abstract][Full Text] [Related]
4. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype.
Kusinski LC; Stanley JL; Dilworth MR; Hirt CJ; Andersson IJ; Renshall LJ; Baker BC; Baker PN; Sibley CP; Wareing M; Glazier JD
Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R86-93. PubMed ID: 22552791
[TBL] [Abstract][Full Text] [Related]
5. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction.
Thaete LG; Kushner DM; Dewey ER; Neerhof MG
Placenta; 2005; 26(2-3):242-50. PubMed ID: 15708126
[TBL] [Abstract][Full Text] [Related]
6. Endothelial NO synthase augments fetoplacental blood flow, placental vascularization, and fetal growth in mice.
Kulandavelu S; Whiteley KJ; Bainbridge SA; Qu D; Adamson SL
Hypertension; 2013 Jan; 61(1):259-66. PubMed ID: 23150513
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor antagonist has limited access to the fetal compartment during chronic maternal administration late in pregnancy.
Thaete LG; Khan S; Synowiec S; Dayton BD; Bauch J; Neerhof MG
Life Sci; 2012 Oct; 91(13-14):583-6. PubMed ID: 22406077
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat.
Neerhof MG; Synowiec S; Khan S; Thaete LG
Hypertens Pregnancy; 2011; 30(1):28-36. PubMed ID: 21265058
[TBL] [Abstract][Full Text] [Related]
9. The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction.
Charnock JC; Dilworth MR; Aplin JD; Sibley CP; Westwood M; Crocker IP
Am J Physiol Endocrinol Metab; 2016 Jan; 310(1):E24-31. PubMed ID: 26530156
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.
Dilworth MR; Andersson I; Renshall LJ; Cowley E; Baker P; Greenwood S; Sibley CP; Wareing M
PLoS One; 2013; 8(10):e77748. PubMed ID: 24204949
[TBL] [Abstract][Full Text] [Related]
11. Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction.
Stanley JL; Andersson IJ; Hirt CJ; Moore L; Dilworth MR; Chade AR; Sibley CP; Davidge ST; Baker PN
Biol Reprod; 2012 Jul; 87(1):25, 1-8. PubMed ID: 22423051
[TBL] [Abstract][Full Text] [Related]
12. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes.
Dieber-Rotheneder M; Beganovic S; Desoye G; Lang U; Cervar-Zivkovic M
Life Sci; 2012 Oct; 91(13-14):710-5. PubMed ID: 22580289
[TBL] [Abstract][Full Text] [Related]
13. Evidence of adaptation of maternofetal transport of glutamine relative to placental size in normal mice, and in those with fetal growth restriction.
McIntyre KR; Hayward CE; Sibley CP; Greenwood SL; Dilworth MR
J Physiol; 2019 Oct; 597(19):4975-4990. PubMed ID: 31400764
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 signaling in the placenta requires endothelial nitric oxide synthase to support trophoblast function and normal fetal growth.
Wilson RL; Troja W; Sumser EK; Maupin A; Lampe K; Jones HN
Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R653-R662. PubMed ID: 33621475
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide deficiency results in abnormal placental metabolism.
George H; Steeves KL; Mercer GV; Aghaei Z; Schneider CM; Cahill LS
Placenta; 2022 Oct; 128():36-38. PubMed ID: 36058049
[TBL] [Abstract][Full Text] [Related]
16. The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.
Dai Y; Zhang J; Liu R; Xu N; Yan SB; Chen Y; Li TH
J Assist Reprod Genet; 2020 May; 37(5):1083-1095. PubMed ID: 32215825
[TBL] [Abstract][Full Text] [Related]
17. The significance of endothelin in platelet-activating factor-induced fetal growth restriction.
Neerhof MG; Khan S; Synowiec S; Qu XW; Thaete LG
Reprod Sci; 2012 Nov; 19(11):1175-80. PubMed ID: 22534337
[TBL] [Abstract][Full Text] [Related]
18. Crossing mice deficient in eNOS with placental-specific Igf2 knockout mice: a new model of fetal growth restriction.
Dilworth MR; Kusinski LC; Baker BC; Renshall LJ; Baker PN; Greenwood SL; Wareing M; Sibley CP
Placenta; 2012 Dec; 33(12):1052-4. PubMed ID: 23099110
[TBL] [Abstract][Full Text] [Related]
19. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of placental neuropilin-1 in fetal growth restriction.
Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
